Immune tolerance network - clinical site monitoring group

Ended Definitive Contract Awarded Last action

Contract number
HHSN266200400070C
Awardee
Awarding agency
Obligated
$13,002,687

Award facts

Opportunity
  • NIHNIAIDDAIT0446 Solicitation number
Contract value 69% obligated
  • $13,002,686.54 Current, with exercised options
  • $18,792,842.54 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers
Pricing
Cost Plus Fixed Fee
Place of performance
Cape Fear, NC 28401, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 15 -$0
Other Administrative Action 14 $0
Funding Only Action 13 $329,186
Other Administrative Action 12 $0
Other Administrative Action 11 $409,533
Funding Only Action 10 $1,747,699
Funding Only Action 9 $1,967,311
Funding Only Action 8 $278,045
Funding Only Action 7 $1,797,101
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Funding Only Action 4 $18,963
Funding Only Action 3 $1,725,795
Funding Only Action 2 $1,693,943
Funding Only Action 1 $1,434,583
Original award $1,600,528
Show all 16

About this award

This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The $18,792,842.54 contract is for the Immune Tolerance Network - Clinical Site Monitoring Group, which involves comprehensive clinical trial and research support services such as regulatory affairs, clinical site monitoring, data management, and analytical testing to support the development of vaccines, therapeutics, diagnostics, and medical countermeasures. The contract does not have a set-aside designation, and PPD has provided services for various NIH, Department of Defense, and Department of Health and Human Services initiatives, including COVID-19 studies, acute respiratory distress syndrome trials, and clinical site monitoring. PPD also holds several significant Indefinite Delivery Vehicles with NIAID and other agencies for a wide range of research and development activities.

Quick answers

Who was awarded contract HHSN266200400070C?

HHSN266200400070C was awarded to PPD Development LP by NIAID DEA OA Acquisitions (National Institutes of Health) on September 15, 2004.

How much is contract HHSN266200400070C worth?

The government has obligated $13,002,687 on HHSN266200400070C. Its potential value, with all options, is $18,792,843.

Was contract HHSN266200400070C competed?

The extent of competition for HHSN266200400070C was full and open competition. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award